Head to Head Review: InMode (INMD) versus The Competition

InMode (NASDAQ:INMD – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare InMode to similar companies based on the strength of its profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for InMode and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InMode 1 3 1 0 2.00
InMode Competitors 4311 10599 18393 838 2.46

InMode presently has a consensus price target of $16.33, indicating a potential upside of 24.21%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 22.33%. Given InMode’s higher possible upside, analysts clearly believe InMode is more favorable than its peers.

Risk & Volatility

InMode has a beta of 1.98, meaning that its share price is 98% more volatile than the S&P 500. Comparatively, InMode’s peers have a beta of 2.58, meaning that their average share price is 158% more volatile than the S&P 500.

Valuation & Earnings

This table compares InMode and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
InMode $370.49 million $93.83 million 10.87
InMode Competitors $1.88 billion $137.20 million 5.73

InMode’s peers have higher revenue and earnings than InMode. InMode is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares InMode and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
InMode 19.94% 11.52% 10.16%
InMode Competitors -300.70% -179.63% -22.71%

Institutional and Insider Ownership

68.0% of InMode shares are owned by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 6.9% of InMode shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

InMode peers beat InMode on 7 of the 13 factors compared.

About InMode

(Get Free Report)

InMode Ltd. is an Israel-based medical technology company that develops energy-based systems for minimally invasive aesthetic and medical procedures. Its technologies use radiofrequency energy to support treatments such as body contouring, skin tightening and facial rejuvenation, as well as certain women’s health applications. The company’s product portfolio includes platforms and handpieces such as BodyTite and FaceTite for body and facial contouring, and Morpheus8 for fractional radiofrequency skin treatments.

Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.